e-learning
resources
London 2016
Monday, 05.09.2016
Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)?
Louis-Marie Galerneau (Grenoble, France), Louis-Marie Galerneau, Jean-Louis Pépin, Anne-Laure Borel, Olivier Chabre, Marc Sapene, Bruno Stach, Janie Girey-Rannaud, Renaud Tamisier, Philippe Caron
Source:
International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Session:
Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Session type:
Oral Presentation
Number:
1802
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Louis-Marie Galerneau (Grenoble, France), Louis-Marie Galerneau, Jean-Louis Pépin, Anne-Laure Borel, Olivier Chabre, Marc Sapene, Bruno Stach, Janie Girey-Rannaud, Renaud Tamisier, Philippe Caron. Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)?. Eur Respir J 2016; 48: Suppl. 60, 1802
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Respiratory physiology
Related content which might interest you:
Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity?
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015
Differences in prevalence of metabolic syndrome (MS) between male and female patients with moderate and severe obstructive sleep apnea. The definition is certainly an important factor
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities?
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain)
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
The effects of obstructive sleep apnea on cardiovascular functioning in children with obesity
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013
The investigation of relationship between red cell distribution width and cardiovascular diseases in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013
Evaluation of lipid profile in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Prevalence of obesity hypoventilation syndrome in OSA patients in the UAE
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013
Obstructive sleep apnea syndrome and cardiometabolic disorders – Is there an association?
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Prevalence and diagnosis of obesity hypoventilation syndrome (OHS) in ambulatory obese patients
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016
Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA)
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Prevalence of metabolic syndrome (MS) in a population of apneic patients:
A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Obstructive sleep apnoea syndrome and a calculation of cardiovascular risk
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept